About this trial
The current study focuses on clinical validation of efficacy of nutraceutical product in reduction of stress,anxiety and improving mood in adults. Adults experiencing chronic stress and anxiety often suffer from a reduced quality of life, marked by symptoms such as irritability, fatigue, and difficulty concentrating. By integrating these gummies into their daily routine, many report noticeable improvements in their emotional and mental state. These enhancements can manifest as increased energy levels, better sleep quality, and a more balanced mood, which collectively contribute to a more positive outlook on life.
Eligibility criteria
Qualifiers
Male and female participants aged 21-50 years both inclusive
Suffering from self-reported mild to moderate stress on the PSS scale score less than or equal to 26
Participants willing to participate in clinical trials and who have read understood and signed the informed consent form
No severe anxiety and depression i.e. Generalized anxiety disorder GAD score less than or equal to 10 and Patients' health questionnaire-9 PHQ-9 score less than or equal to 14
Disqualifiers
Inability to perform any of the assessments required for endpoint analysis
Shows signs of dementia, such as caused by Alzheimer's Disease, acquired immunodeficiency syndrome (AIDS), Creutzfeldt-Jakob disease (CJD), Lewy Bodies dementia (LBD), Cerebrovascular dementia (CVD), Progressive Supranuclear Palsy (PSP), multiple cerebral infarctions, or normal pressure hydrocephalus (NPH)
Participants currently using any nutraceutical, allopathic, or ayurvedic supplement for stress management
Have any other neurodegenerative diseases or seizure disorder
Trial design
Treatments tested in this trial
- De-Stress and Chill Gummies-U001
- De-Stress and Chill Gummies-I001
- Placebo Gummies-001